These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12236924)

  • 1. [Permanent atrial fibrillation in heart disease in Spain. The CARDIOTENS study 1999].
    García-Acuña JM; González-Juanatey JR; Alegría Ezquerra E; González Maqueda I; Listerri JL
    Rev Esp Cardiol; 2002 Sep; 55(9):943-52. PubMed ID: 12236924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing stroke in people with atrial fibrillation: a cross-sectional study.
    de Lusignan S; van Vlymen J; Hague N; Thana L; Dzregah B; Chan T
    J Public Health (Oxf); 2005 Mar; 27(1):85-92. PubMed ID: 15590708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of atrial fibrillation in preterminal inpatients aged 60 years and over.
    Yang JF; Liu B; Liu DG; Luo Y; Fang F
    Chin Med J (Engl); 2008 Oct; 121(20):2046-9. PubMed ID: 19080273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon.
    Ntep-Gweth M; Zimmermann M; Meiltz A; Kingue S; Ndobo P; Urban P; Bloch A
    Europace; 2010 Apr; 12(4):482-7. PubMed ID: 20179174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands--The EXAMINE-AF study. A questionnaire survey.
    Dinh T; Nieuwlaat R; Tieleman RG; Büller HR; van Charante NA; Prins MH; Crijns HJ
    Int J Clin Pract; 2007 Jan; 61(1):24-31. PubMed ID: 17229177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with atrial fibrillation in a primary care setting: Val-FAAP study.
    Barrios V; Calderón A; Escobar C; de la Figuera M;
    Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):47-53. PubMed ID: 22054913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of antithrombotic drugs in patients with chronic atrial fibrillation in a local health area].
    Aloy-Duch A; Cuenca-Luque R; Rollán-Serrano E; Casanova-Sandoval JM
    Med Clin (Barc); 1999 Apr; 112(12):454-6. PubMed ID: 10320959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant treatment of patients with chronic atrial fibrillation in primary health care in Sweden--a retrospective study of incidence and quality in a registered population.
    Nilsson GH; Björholt I; Krakau I
    Fam Pract; 2004 Dec; 21(6):612-6. PubMed ID: 15465879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology, risk factors, and pathogeny of atrial fibrillation and atrial flutter].
    Berjón Reyero J; Olaz Preciado F; de los Arcos Lage E
    Rev Esp Cardiol; 1996; 49 Suppl 2():1-7. PubMed ID: 8755690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France.
    ; Leizorovicz A; Cohen A; Guenoun M; Mismetti P; Weisslinger N
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):32-8. PubMed ID: 17063535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective investigation of hospitalised patients with atrial fibrillation in mainland China.
    Wen-Hang QI;
    Int J Cardiol; 2005 Dec; 105(3):283-7. PubMed ID: 16274769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
    Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
    Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis.
    Goto S; Bhatt DL; Röther J; Alberts M; Hill MD; Ikeda Y; Uchiyama S; D'Agostino R; Ohman EM; Liau CS; Hirsch AT; Mas JL; Wilson PW; Corbalán R; Aichner F; Steg PG;
    Am Heart J; 2008 Nov; 156(5):855-63, 863.e2. PubMed ID: 19061698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
    Curtis AB; Gersh BJ; Corley SD; DiMarco JP; Domanski MJ; Geller N; Greene HL; Kellen JC; Mickel M; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
    Am Heart J; 2005 Apr; 149(4):645-9. PubMed ID: 15990747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of paroxysmal atrial fibrillation depending on the regression of left ventricular hypertrophy in arterial hypertension.
    Hennersdorf MG; Schueller PO; Steiner S; Strauer BE
    Hypertens Res; 2007 Jun; 30(6):535-40. PubMed ID: 17664857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study.
    Laguna P; Martn A; del Arco C; Gargantilla P;
    Ann Emerg Med; 2004 Jul; 44(1):3-11. PubMed ID: 15226703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.